Factory shutdowns across China because of the new coronavirus have exposed an uncomfortable health-care reality: Many medicines rely on raw materials that are made in that country.
Health & Wellness
There’s been an overwhelming amount of information in a short time. This guide can help steer you to our best coverage so far.
Public health officials say a U.S. outbreak is inevitable. What precautions should you take?
Hospitals and public-health officials in the U.S. and Europe are rationing medical masks and scrounging for more, as they prepare for a potential widening of the coronavirus epidemic.
Gilead Sciences said its own late-stage studies of the experimental coronavirus drug remdesivir would start in March, accelerating plans for what it hopes could be the first medicine specifically approved to treat the respiratory disease.
Researchers have started trials in the U.S. of an experimental drug from Gilead Sciences aimed at treating the novel coronavirus, the National Institutes of Health said.
Moderna has shipped the first batch of the company’s rapidly developed coronavirus vaccine to researchers at the National Institute of Allergy and Infectious Diseases.
Johnson & Johnson, Sanofi and Inovio Pharmaceuticals have started to develop coronavirus vaccines. The efforts come as Moderna has shipped a batch of its coronavirus vaccine to U.S. researchers for human testing.
For years, ADHD has been considered a disorder of kids and younger adults. Now, doctors are realizing older people have it too—and it’s sometimes mistaken for dementia.
Some of the largest health insurers are steering patients toward clinics they now own as a result of recent massive deals that have given them control over both health-care delivery and payment.
A photographer worked out at least five days a week, but he still wasn’t seeing results. Then he discovered weightlifting.
Americans struggling to lower their cholesterol will have another drug at their disposal, after the FDA approved a new medicine from Esperion Therapeutics.
President Trump’s plan to champion his health-care record in the 2020 election race faces a problem: He has so far failed to deliver on a pledge to bring down drug prices.
A first-of-its-kind program in Utah trains volunteers in an effort to relieve caregivers and alleviate symptoms like agitation and aggression.
An administration proposal would impose new reporting requirements and restrictions on financial practices used by states to pay for Medicaid. Some governors and health-care companies say it threatens funding for the program.
An $18 billion settlement offer from three major drug wholesalers to resolve litigation over the opioid crisis has fallen apart, after more than 20 state attorneys general rejected it in a letter earlier this week.
Drugmaker Gilead Sciences has provided a drug for testing in two clinical trials in China that are exploring whether the agent works against the spreading coronavirus.
In the latest failed attempt to help people with Alzheimer’s, a study found that experimental drugs from Lilly and Roche failed to help people with a rare, inherited form of the dementia-causing disease.
A graduate student blows off steam by helping a team power their canoe through the frigid waters of Calgary’s Bow River.
Robert Montgomery has resumed performing surgery after receiving a heart transplant from a donor with hepatitis C. But his journey back hasn’t been without complications.